These effects on PPARα and SREBP-1c may be mediated by ethanol metabolism rather than by ethanol exposure per se, since inhibition of ethanol oxidation by 4-methylpyrazole, an ADH inhibitor, blocked these effects in rat hepatoma cell lines [27,28]. Here, SREBF1 is linked to hepatocellular carcinoma.